A Louisiana nurse practitioner received an 87-month federal prison sentence on June 17 for causing more than $12 million in false Medicare claims involving unnecessary cancer genetic tests. The court also imposed three years of supervised release and more than $1.5 million in restitution. The dated case explains how a short telehealth interaction can become an expensive order in a beneficiary’s Medicare history.
The orders followed calls lasting less than 30 seconds
The Justice Department said Scharmaine Lawson Baker worked as an independent contractor for a company claiming to provide telehealth services. She signed hundreds of orders for cancer genetic tests after brief telephone calls, often without examining the patients or establishing that the tests were medically necessary.
The June sentencing announcement says the scheme caused more than $12.1 million in false claims and laboratories received over $1.5 million in Medicare reimbursements. Those are different figures: billed claims measure attempted program cost, while reimbursements reflect money actually paid to the labs.
Free retirement updates: Protecting retirement savings starts with knowing which threats are real. Our free Retirement Shield newsletter covers scams, benefits, and money deadlines a couple times a week. Get the free newsletter.
Kickbacks separated the order from patient need
Prosecutors said Lawson Baker received illegal payments for signing the testing orders. Evidence showed that the telehealth company expected volume, while medical necessity and follow-up were neglected. She did not review test results, including results indicating variants associated with cancer risk.
The government also described orders for ovarian and cervical cancer tests involving male patients. That mismatch is an obvious warning, but many unnecessary orders are harder for a patient to recognize. A test may sound advanced or preventive even when the provider has not taken the history needed to justify it.
A Medicare statement can reveal a test the patient never discussed
Beneficiaries can review Medicare Summary Notices for the provider, service, date, amount billed, amount approved, and amount owed. An unfamiliar laboratory or genetic test should be compared with appointments and any specimen collection. A zero-dollar patient balance does not make an unauthorized claim harmless.
False claims consume program funds and may place inaccurate information in medical records. They can also signal that a Medicare number or personal information is circulating among marketers. Questions should go to the clinician and laboratory through independently verified contact information, followed by Medicare if the explanation does not match.
“Free” genetic testing can carry a hidden billing route
Fraud operations often recruit through calls, health fairs, online advertisements, or mailed kits and say Medicare will cover everything. The beneficiary may be asked to provide a Medicare number and complete a minimal questionnaire. A distant practitioner then signs an order without a meaningful treatment relationship.
Coverage depends on medical necessity and Medicare rules, not a marketer’s assurance. Before providing an identifier or specimen, the patient can ask the treating doctor whether the test is appropriate, which laboratory will perform it, how results will change care, and who will explain the result.
Medicare identifiers should be treated like financial credentials
A Medicare number can be used to submit claims even when a scammer never obtains a bank password. Beneficiaries should not give it to unsolicited callers offering braces, genetic tests, pain creams, or other products. A caller’s knowledge of the person’s diagnosis or physician does not prove authorization.
Suspected misuse can be reported to Medicare and the HHS Office of Inspector General. Keeping the call number, company name, mailing label, order paperwork, and statement entries helps investigators connect marketing, ordering, and billing participants.
The sentence followed a jury conviction
A federal jury convicted Lawson Baker in July 2025 on six health-care-fraud counts after a three-day trial. The prison term came later, in June 2026. Separating conviction from sentencing prevents an old verdict from being presented as a new finding.
The court’s restitution amount of $1,508,868.25 is also not a payment program for individual Medicare beneficiaries. It is part of the criminal judgment. Anyone claiming a beneficiary must pay a fee to receive a share is misrepresenting the case.
A short call should not create a long medical record
The enforcement record shows a chain: telemarketing, a cursory phone contact, a paid signature, a laboratory test, and a Medicare claim. Beneficiaries can interrupt that chain by involving a treating clinician before testing and reviewing claims afterward.
The June sentence documents serious consequences for one provider, but the household protection step is routine. Open each Medicare notice, question unfamiliar services promptly, and protect the identifier used to bill the program. A claim caught early can prevent repeated billing and help expose the network behind it.
This article was created with AI assistance and was reviewed, edited, and fact-checked by The Financial Wire editorial team.
More Financial Reading
- How many CDs can you park at 1 bank? FDIC rules you must know
- Adding someone to your bank account: tax traps and smart moves
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
